A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Michael A. Carducci David C. Smith Suzanne Kamel-Reid |
| Publication date | May 3, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |